Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II trial evaluates use of radiosensitizer AGuIX in brain metastases

April 8, 2019

Celltrion and iProgen partner to develop ADCs

April 8, 2019

CE mark for radioenhancer Hensify for locally advanced soft tissue sarcoma

April 8, 2019

DNA methylation marks in ELOVL2 gene as promising epigenetic biomarkers of early-stage AD

April 8, 2019

Phase Ia data presented for anti-EGFR antibody-drug conjugate AVID-100

April 8, 2019

Eli Lilly presents population PK data for LY-3295668 erbumine in patients with advanced solid tumors

April 8, 2019

ITRI-E-212 demonstrates promising safety and IOP-lowering effects in vivo

April 8, 2019

Arcus Biosciences presents AB-680, a potent and selective inhibitor of CD73

April 8, 2019

DE Shaw Research discovers GTPase KRas inhibitors

April 8, 2019

Keeping bacteria from genome gambling slows resistance evolution

April 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...